Research area
Health & Longevity
Human health, disease, treatment and aging. The largest corpus area supports distinct cancer, neurological and therapeutic navigation.
-
Evidence date ·How lingering stressed cells may connect kidney injury to scarring
Review or Meta-AnalysisPersistent senescent cells may promote kidney scarring. Human data are observational; animal experiments suggest a causal role, but patient benefit is unproven.
-
Evidence date ·How signals around a broken bone change as it heals
Review or Meta-AnalysisA March 2026 review maps signals associated with senescence across fracture repair. Mouse drug results are encouraging, but patient benefit remains unproven.
-
Evidence date ·Could targeting stressed brain cells help people with neurodegenerative disease?
Review or Meta-AnalysisA review describes signs of senescence in different brain cells across Alzheimer’s, Parkinson’s and multiple sclerosis. A five-person pilot found no significant cognitive change.
-
Evidence date ·Could natural killer cells help older adults stay healthy?
Review or Meta-AnalysisA 2026 review connects aging-related changes in natural killer cells with immune surveillance. Tests and preventive treatments still need validation.
-
Evidence date ·How a lifelong virus may affect health during effective HIV treatment
Review or Meta-AnalysisA 2026 review explores how cytomegalovirus may sustain inflammation during treated HIV. Early letermovir results do not show that the drug prevents illness.
-
Evidence date ·How might virus-shaped particles guide a cancer vaccine’s immune signal to lymph nodes?
Review or Meta-AnalysisA review discusses dendritic-cell-mediated targeting and lymphatic drainage as distinct strategies for virus-like particles. Production and immune variability remain hurdles.
-
Evidence date ·Why cancer vaccine exosomes need more than the right cargo
Review or Meta-AnalysisA March 2026 review compares ways to load tumor antigens into exosomes and direct the vesicles toward immune cells. Early human studies show limited, varied responses.
-
Evidence date ·What changed in mouse memory and brain immune cells after resveratrol?
Peer-Reviewed PaperIn an accelerated-aging mouse model, resveratrol improved maze performance and lowered brain inflammatory markers. Cultured cells showed reduced STING pathway signaling.
-
Evidence date ·Venetoclax combination reports had a higher share of life-threatening outcomes but a lower share of deaths
Peer-Reviewed PaperVenetoclax reports more often noted low white blood cell counts and life-threatening outcomes with combinations than with monotherapy. The study cannot measure risk.
-
Evidence date ·What did scans and blood tests find in personnel with years of blast exposure?
Peer-Reviewed PaperResearchers compared brain scans and blood markers in active-duty personnel with long blast-exposure histories. A small, one-time study cannot establish cause or future risk.